Figures from this paper
4 Citations
Comparison of remdesivir and favipiravir - the anti-Covid-19 agents mimicking purine RNA constituents.
- Medicine, BiologyBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
- 2021
Favipiravir has shown various benefits when administered in mild and moderate cases of COVID-19, while remdesivir was more beneficial in more severe cases of the disease, and the evidence in favor of favipirs is compromised by the small number and low-quality of trials conducted.
Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community
- Medicine, BiologyResearch
- 2020
Advances and challenges in the rapid detection of COVID-19 by targeting nucleic acids, antigens, or antibodies are reviewed and potential treatments and vaccines against CO VID-19 are summarized.
Prescribed drugs containing nitrogen heterocycles: an overview
- ChemistryRSC advances
- 2020
Heteroatoms as well as heterocyclic scaffolds are frequently present as the common cores in a plethora of active pharmaceuticals natural products. Statistically, more than 85% of all biologically…
References
SHOWING 1-10 OF 344 REFERENCES
Emerging antiviral drugs.
- Biology, MedicineExpert opinion on emerging drugs
- 2008
Among the newly described antiviral agents that may be developed into drugs are, for the treatment of human papilloma virus (HPV) infections, cPrPMEDAP and cyclosporin A derivatives such as the non-immunosuppressive Debio-025.
Antiviral strategies against influenza virus: towards new therapeutic approaches
- BiologyCellular and Molecular Life Sciences
- 2014
An overview of novel strategies targeting the virus and/or the host cell for counteracting influenza virus infection and several new classes of antiviral agents targeting viral replication mechanisms or cellular proteins/processes are under development.
Recent highlights in the development of new antiviral drugs
- Medicine, BiologyCurrent Opinion in Microbiology
- 2005
Antiviral drugs in current clinical use.
- Medicine, BiologyJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
- 2004
The current armamentarium for the chemotherapy of viral infections consists of 37 licensed antiviral drugs and the combination of ribavirin with (pegylated) interferon-alpha has received increased acceptance for the treatment of hepatitis C virus (HCV) infections.
Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection
- BiologyAntiviral Research
- 2012
Antiviral agents active against influenza A viruses
- BiologyNature reviews. Drug discovery
- 2006
Key PointsSeveral drugs are available that could be used, either alone or in combination, for the treatment (prophylaxis or therapy) of an influenza pandemic. These include adamantan(amin)e…